Compounds > catechol-3,6-bis(methyleneiminodiacetic acid)
Page last updated: 2024-09-04

catechol-3,6-bis(methyleneiminodiacetic acid) and deferiprone

catechol-3,6-bis(methyleneiminodiacetic acid) has been researched along with deferiprone in 1 studies

Compound Research Comparison

Studies
(catechol-3,6-bis(methyleneiminodiacetic acid))		Trials
(catechol-3,6-bis(methyleneiminodiacetic acid))		Recent Studies (post-2010)
(catechol-3,6-bis(methyleneiminodiacetic acid))		Studies
(deferiprone)		Trials
(deferiprone)		Recent Studies (post-2010) (deferiprone)
12031,016142409

Protein Interaction Comparison

ProteinTaxonomycatechol-3,6-bis(methyleneiminodiacetic acid) (IC50)deferiprone (IC50)
Lysine-specific demethylase 6AHomo sapiens (human)4.2
Lysine-specific demethylase 4AHomo sapiens (human)3.275
Lysine-specific demethylase 5CHomo sapiens (human)5.6
Lysine-specific demethylase 2BHomo sapiens (human)8.1
Deoxyhypusine hydroxylaseHomo sapiens (human)5
Lysine-specific demethylase 2AHomo sapiens (human)6.8

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukuda, S1

Reviews

1 review(s) available for catechol-3,6-bis(methyleneiminodiacetic acid) and deferiprone

ArticleYear
Chelating agents used for plutonium and uranium removal in radiation emergency medicine.
    Current medicinal chemistry, 2005, Volume: 12, Issue:23

    Topics: Animals; Aza Compounds; Catechols; Chelating Agents; Deferiprone; Diphosphonates; Emergency Medicine; Humans; Iron Chelating Agents; Pentetic Acid; Plutonium; Pyridones; Radiation Injuries; Uranium

2005